Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

LYNBROOK, N.Y., Oct. 23, 2019 /PRNewswire/ — BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today…

About the Author

has written 41779 stories on this site.

Copyright © 2010 Business and Corporate News.